BioCryst Announces Approval of ORLADEYO® for Pediatric HAE Patients in Japan

Globe Newswire•25/08/2026•07:01 ET

0

Whiz Insights

Get started

Create a free account to read the full story.

Already have an account? Log in

Forgot password?